Search Results 811-820 of 18674 for Relapse
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...
Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): An International Myeloma Working Group study. Blood ...
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...
A Study To Investigate Safety And Effectiveness Of BGB-16673 In Combination With Other Agents In Participants With Relapsed Or Refractory B-Cell Malignancies.
Study shows drug reduces risk of relapse with neuromyelitis optica featured image. Featured News. Study shows drug reduces risk of relapse with neuromyelitis ...
Patients enrolled in the lead-in phase of this study are required to have relapsed following a prior autologous or allogeneic HSCT, or to be ineligible for HSCT ...
However, relapse rates and risk of developing ESRD were higher for ... relapses with cyclophosphamide therapy. Therefore, mycophenolate mofetil should ...
Relapse with active GCA within 6 weeks of study entry where active disease is defined by an ESR ≥ 30 mm/hr or CRP ≥10 mg/L AND the presence of at least ...
... Relapse in Subjects with Substance Use Disorders Rochester, MN. Impulsivity is a major component of addictive behavior contributing to the initiation and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.